208 related articles for article (PubMed ID: 31559035)
21. The Impact of Antithrombin III Use in Achieving Anticoagulant Goals in Pediatric Patients.
Jones AJ; O'Mara KL; Kelly BJ; Samraj RS
J Pediatr Pharmacol Ther; 2017; 22(5):320-325. PubMed ID: 29042831
[TBL] [Abstract][Full Text] [Related]
22. Antithrombin supplementation in adult patients receiving extracorporeal membrane oxygenation.
Morrisette MJ; Zomp-Wiebe A; Bidwell KL; Dunn SP; Gelvin MG; Money DT; Palkimas S
Perfusion; 2020 Jan; 35(1):66-72. PubMed ID: 31213179
[TBL] [Abstract][Full Text] [Related]
23. Continuous Antithrombin III Administration in Pediatric Veno-Arterial Extracorporeal Membrane Oxygenation.
Nelson KM; Hansen LA; Steiner ME; Fischer GA; Dehnel J; Gupta S
J Pediatr Pharmacol Ther; 2017; 22(4):266-271. PubMed ID: 28943821
[TBL] [Abstract][Full Text] [Related]
24. Anticoagulation and Transfusions Management in Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Assessment of Factors Associated With Transfusion Requirements and Mortality.
Martucci G; Panarello G; Occhipinti G; Ferrazza V; Tuzzolino F; Bellavia D; Sanfilippo F; Santonocito C; Bertani A; Vitulo P; Pilato M; Arcadipane A
J Intensive Care Med; 2019 Aug; 34(8):630-639. PubMed ID: 28460592
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Bivalirudin During Adult Extracorporeal Membrane Oxygenation: A Retrospective Characterization of Dosing, Efficacy and Bleeding.
Lopez ND; Seto SL; Barra ME; Roberts RJ; Rosovsky RP; Solomon EJ; Dalia A
Hosp Pharm; 2024 Feb; 59(1):77-85. PubMed ID: 38223854
[No Abstract] [Full Text] [Related]
26. Performance Assessment of a Multifaceted Unfractionated Heparin Dosing Protocol in Adult Patients on Extracorporeal Membrane Oxygenator.
Al-Jazairi A; Raslan S; Al-Mehizia R; Dalaty HA; De Vol EB; Saad E; Alanazi M; Owaidah T
Ann Pharmacother; 2021 May; 55(5):592-604. PubMed ID: 32959678
[TBL] [Abstract][Full Text] [Related]
27. Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO Study.
Martucci G; Giani M; Schmidt M; Tanaka K; Tabatabai A; Tuzzolino F; Agerstrand C; Riera J; Ramanan R; Grasselli G; Ait Hssain A; Gannon WD; Buabbas S; Gorjup V; Trethowan B; Rizzo M; Fanelli V; Jeon K; De Pascale G; Combes A; Ranieri MV; Duburcq T; Foti G; Chico JI; Balik M; Broman LM; Schellongowski P; Buscher H; Lorusso R; Brodie D; Arcadipane A;
Am J Respir Crit Care Med; 2024 Feb; 209(4):417-426. PubMed ID: 37943110
[No Abstract] [Full Text] [Related]
28. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of an aPTT guided versus a multimodal heparin monitoring approach in patients on extra corporeal membrane oxygenation: A retrospective cohort study.
Taha D; Drop JG; Wildschut ED; De Hoog M; van Ommen CH; Reis Miranda DD
Perfusion; 2024 May; ():2676591241253474. PubMed ID: 38739366
[TBL] [Abstract][Full Text] [Related]
30. Validation of Nafamostat Mesilate as an Anticoagulant in Extracorporeal Membrane Oxygenation: A Large-Animal Experiment.
Han SJ; Han W; Song HJ; Kim CS; Jeong SM; Kang MW
Korean J Thorac Cardiovasc Surg; 2018 Apr; 51(2):114-121. PubMed ID: 29662809
[TBL] [Abstract][Full Text] [Related]
31. Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation.
Aubron C; DePuydt J; Belon F; Bailey M; Schmidt M; Sheldrake J; Murphy D; Scheinkestel C; Cooper DJ; Capellier G; Pellegrino V; Pilcher D; McQuilten Z
Ann Intensive Care; 2016 Dec; 6(1):97. PubMed ID: 27714705
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Antithrombin III Products in Pediatric Patients Receiving Extracorporeal Membrane Oxygenation.
Omecene NE; Kishk OA; Lardieri AB; Walker LK; Bhutta AT
ASAIO J; 2020; 66(9):1042-1047. PubMed ID: 31977357
[TBL] [Abstract][Full Text] [Related]
33. Antithrombin replacement during extracorporeal membrane oxygenation.
Niebler RA; Christensen M; Berens R; Wellner H; Mikhailov T; Tweddell JS
Artif Organs; 2011 Nov; 35(11):1024-8. PubMed ID: 22097980
[TBL] [Abstract][Full Text] [Related]
34. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.
Ranucci M; Ballotta A; Kandil H; Isgrò G; Carlucci C; Baryshnikova E; Pistuddi V;
Crit Care; 2011; 15(6):R275. PubMed ID: 22099212
[TBL] [Abstract][Full Text] [Related]
35. aPTT-guided anticoagulation monitoring during ECMO support: A systematic review and meta-analysis.
Rajsic S; Treml B; Jadzic D; Breitkopf R; Oberleitner C; Bachler M; Bösch J; Bukumiric Z
J Crit Care; 2023 Oct; 77():154332. PubMed ID: 37244207
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support.
Arnouk S; Altshuler D; Lewis TC; Merchan C; Smith DE; Toy B; Zakhary B; Papadopoulos J
ASAIO J; 2020 Mar; 66(3):300-306. PubMed ID: 31045921
[TBL] [Abstract][Full Text] [Related]
37. Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review.
Netley J; Roy J; Greenlee J; Hart S; Todt M; Statz B
J Extra Corpor Technol; 2018 Sep; 50(3):161-166. PubMed ID: 30250342
[TBL] [Abstract][Full Text] [Related]
38. A perioperative bivalirudin anticoagulation protocol for neonates with congenital diaphragmatic hernia on extracorporeal membrane oxygenation.
Snyder CW; Goldenberg NA; Nguyen ATH; Smithers CJ; Kays DW
Thromb Res; 2020 Sep; 193():198-203. PubMed ID: 32763642
[TBL] [Abstract][Full Text] [Related]
39. Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study.
Cartwright B; Bruce HM; Kershaw G; Cai N; Othman J; Gattas D; Robson JL; Hayes S; Alicajic H; Hines A; Whyte A; Chaikittisilpa N; Southwood TJ; Forrest P; Totaro RJ; Bannon PG; Dunkley S; Chen VM; Dennis M
Sci Rep; 2021 Apr; 11(1):7975. PubMed ID: 33846433
[TBL] [Abstract][Full Text] [Related]
40. Incidence of Platelet Dysfunction by Thromboelastography-Platelet Mapping in Children Supported with ECMO: A Pilot Retrospective Study.
Saini A; Hartman ME; Gage BF; Said A; Gazit AZ; Eghtesady P; Boston US; Spinella PC
Front Pediatr; 2015; 3():116. PubMed ID: 26779465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
